http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2191019-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cbb8f769075b864a5323d796cc380105 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-662 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30 |
filingDate | 2000-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2002-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c00893e3540fbfc1bc48c42cbab4885 |
publicationDate | 2002-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2191019-C2 |
titleOfInvention | Method for treating an abstinential syndrome at heroin narcomania |
abstract | FIELD: medicine, narcology. SUBSTANCE: patient's complex of curative medicinal preparations should be supplemented with dimephosphone to be intravenously injected at 60 mg/kg daily at courses the multiplicity and duration of which depend upon the degree of abstinential syndrome at algid stage. EFFECT: higher efficiency of therapy and shortened period of rehabilitation. 2 ex, 1 tbl |
priorityDate | 2000-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.